Reaction
Posterior Capsule Opacification reporting signals
As of the last recalculation, Posterior Capsule Opacification appears in 329 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 111.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 41 | 111.5 | 111.6 |
| Faricimab | 13 | 105.6 | 105.8 |
| Aflibercept | 19 | 40.8 | 40.9 |
| Timolol | 6 | 32.0 | 32.0 |
| Lifitegrast | 4 | 15.7 | 15.7 |